Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOW-RAO: Tinzaparin for Radial Artery Occlusion
NCT04196309Phase 4Completed
- Sponsor
- AHEPA University Hospital
- Start
- May 2017
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tinzaparin in Radial artery occlusion (RAO) (2 arms), sponsored by AHEPA University Hospital. Primary endpoint: Radial artery patency rate at 1 month. Started May 2017; status: completed.
02
Drugs
tinzaparin
03
Conditions
Radial artery occlusion (RAO)
Beyond the preview
Go deeper on NCT04196309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04196309.